Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

NCT04626947 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Sponsor's decision

Conditions

Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn Disease
C. Diff. Infections

Interventions

BIOLOGICAL: Bezlotoxumab

Sponsor

David Binion, MD

Collaborators

[object Object]